Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Adalat GITS nifedipine: Phase IV started

BAY's Bayer Schering Pharma AG unit began the double-blind, European Phase IV TALENT trial

Read the full 147 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE